The First N-terminal Amino Acids of α-Synuclein Are Essential for α-Helical Structure Formation In Vitro and Membrane Binding in Yeast

被引:126
作者
Vamvaca, Katherina
Volles, Michael J.
Lansbury, Peter T., Jr. [1 ]
机构
[1] Harvard Univ, Ctr Neurol Dis, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02139 USA
基金
瑞士国家科学基金会;
关键词
alpha-synuclein; Parkinson's disease; secondary structure; N-terminus; yeast toxicity; A-BETA COMPONENT; DISEASE-LINKED MUTATIONS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; SECONDARY STRUCTURE; FIBRIL FORMATION; PROTEIN; AGGREGATION; MUTANT;
D O I
10.1016/j.jmb.2009.03.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
alpha-Synuclein (alpha-syn), a protein implicated in Parkinson's disease, is structurally diverse. In addition to its random-coil state, alpha-syn can adopt an alpha-helical structure upon lipid membrane binding or a beta-sheet structure upon aggregation. We used yeast biology and in vitro biochemistry to detect how sequence changes alter the structural propensity of alpha-syn. The N-terminus of the protein, which adopts an alpha-helical conformation upon lipid binding, is essential for membrane binding in yeast, and variants that are more prone to forming an alpha-helical structure in vitro are generally more toxic to yeast. beta-Sheet structure and inclusion formation, on the other hand, appear to be protective, possibly by sequestering the protein from the membrane. Surprisingly, sequential deletion of residues 2 through 11 caused a dramatic drop in alpha-helical propensity, vesicle binding in vitro, and membrane binding and toxicity in yeast, part of which Could be mimicked by mutating aspartic acid at position 2 to alanine. Variants with distinct structural preferences, identified here by a reductionist approach, provide valuable tools for elucidating the nature of toxic forms of alpha-syn in neurons. (C) 2009 Published by Elsevier Ltd.
引用
收藏
页码:413 / 424
页数:12
相关论文
共 42 条
[1]
A topological model of the interaction between α-synuclein and sodium dodecyl sulfate micelles [J].
Bisaglia, M ;
Tessari, I ;
Pinato, L ;
Bellanda, M ;
Giraudo, S ;
Fasano, M ;
Bergantino, E ;
Bubacco, L ;
Mammi, S .
BIOCHEMISTRY, 2005, 44 (01) :329-339
[2]
Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity [J].
Bodles, AM ;
Guthrie, DJS ;
Greer, B ;
Irvine, GB .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) :384-395
[3]
Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases [J].
Bodner, RA ;
Outeiro, TF ;
Altmann, S ;
Maxwell, MM ;
Cho, SH ;
Hyman, BT ;
McLean, PJ ;
Young, AB ;
Housman, DE ;
Kazantsev, AG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (11) :4246-4251
[4]
SYNUCLEIN PROTEINS AND ALZHEIMERS-DISEASE [J].
BROOKES, AJ ;
STCLAIR, D .
TRENDS IN NEUROSCIENCES, 1994, 17 (10) :404-405
[5]
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein [J].
Cole, NB ;
Murphy, DD ;
Grider, T ;
Rueter, S ;
Brasaemle, D ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6344-6352
[6]
Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[7]
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[8]
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models [J].
Cooper, Antony A. ;
Gitler, Aaron D. ;
Cashikar, Anil ;
Haynes, Cole M. ;
Hill, Kathryn J. ;
Bhullar, Bhupinder ;
Liu, Kangning ;
Xu, Kexiang ;
Strathearn, Katherine E. ;
Liu, Fang ;
Cao, Songsong ;
Caldwell, Kim A. ;
Caldwell, Guy A. ;
Marsischky, Gerald ;
Kolodner, Richard D. ;
LaBaer, Joshua ;
Rochet, Jean-Christophe ;
Bonini, Nancy M. ;
Lindquist, Susan .
SCIENCE, 2006, 313 (5785) :324-328
[9]
Stabilization of α-synuclein secondary structure upon binding to synthetic membranes [J].
Davidson, WS ;
Jonas, A ;
Clayton, DF ;
George, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9443-9449
[10]
Neural activity controls the synaptic accumulation of α-synuclein [J].
Fortin, DL ;
Nemani, VM ;
Voglmaier, SM ;
Anthony, MD ;
Ryan, TA ;
Edwards, RH .
JOURNAL OF NEUROSCIENCE, 2005, 25 (47) :10913-10921